Viewing Study NCT06963502


Ignite Creation Date: 2025-12-25 @ 3:47 AM
Ignite Modification Date: 2026-01-14 @ 2:28 PM
Study NCT ID: NCT06963502
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-05-09
First Post: 2025-04-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid Tumors
Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module